Evidence map›Paper›PMID 30551202›Full record

ArticleInvestigative ophthalmology & visual science2018

Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months.

Mark E Pennesi, David G Birch, K Thiran Jayasundera, Maria Parker, Ou Tan, Rabia Gurses-Ozden, Carrie Reichley, Kathleen N Beasley, Paul Yang, Richard G Weleber and 5 more

Abstract readEvaluation Study
In one paragraph

Article in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Quality of Life in Patients with Posterior Segment Eye Diseases.Journal of ophthalmic & vision research · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Diurnal functional and anatomical changes in X-linked retinoschisis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  15. Article
  16. X-Linked Retinoschisis.Cold Spring Harbor perspectives in medicine · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Spatial and Temporal Integration Abnormalities in X-Linked Retinoschisis.Investigative ophthalmology & visual science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Mark E PennesiCasey Eye Institute, Oregon Health & Sciences University, Portland, Oregon, United States.
David G BirchRetina Foundation of the Southwest, Dallas, Texas, United States.
K Thiran JayasunderaKellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
Maria ParkerCasey Eye Institute, Oregon Health & Sciences University, Portland, Oregon, United States.
Ou TanCasey Eye Institute, Oregon Health & Sciences University, Portland, Oregon, United States.
Rabia Gurses-OzdenApplied Genetic Technologies Corporation, Alachua, Florida, United States.
Carrie ReichleyApplied Genetic Technologies Corporation, Alachua, Florida, United States.
Kathleen N BeasleyApplied Genetic Technologies Corporation, Alachua, Florida, United States.
Paul YangCasey Eye Institute, Oregon Health & Sciences University, Portland, Oregon, United States.
Richard G WeleberCasey Eye Institute, Oregon Health & Sciences University, Portland, Oregon, United States.
Lea D BennettRetina Foundation of the Southwest, Dallas, Texas, United States.
John R HeckenlivelyKellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
Kalyani KothapalliStatistics and Data Corporation, Tempe, Arizona, United States.
Jeffrey D ChulayApplied Genetic Technologies Corporation, Alachua, Florida, United States.
For The Xlrs-Study Group
Oregon Health & Science University · USApplied Genetic Technologies (United States) · USRetina Foundation of the Southwest · USDataSoft (United States) · USUniversity of Michigan–Ann Arbor · USW.K. Kellogg Foundation · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell · 1995 to 2026
$19.4M
Targeted functional testing for retinal diseases based on patient reported outcomesK23EY026985 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAYASUNDERA, KANISHKA THIRAN · 2016 to 2020
$1.2M
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis PigmentosaK08EY026650 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI YANG, PAUL · 2016 to 2020
$1.1M
Rod photoreceptor function in retinitis pigmentosaK99EY027460 · NEI · RETINA FOUNDATION OF THE SOUTHWEST · PI BENNETT, LEA D · 2017 to 2018
$187k
NEI NIH HHS K08 EY026650NEI NIH HHS K23 EY026985NEI NIH HHS K99 EY027460NEI NIH HHS P30 EY010572
6 · The paper itself

Abstract

Purpose: Prospective evaluation of patients with X-linked retinoschisis (XLRS). Methods: Fifty-six males XLRS patients, age ≥7 years, had retinal structure and function tests performed every 6 months during an 18-month period. Results: Best corrected visual acuity (BCVA) was abnormal (mean ± SD logMAR 0.57 ± 0.32 OD and 0.50 ± 0.27 OS), with weak correlation between visual acuity and age (R = -0.24, P = 0.0095). Mean cyst cavity volume (CCV) determined on optical coherence tomography showed weak correlation with age (R = -0.33, P = 0.0009) and no correlation with visual acuity. Subjects had modest reduction in mean kinetic and static perimetry results, reduced b-wave amplitude on electroretinography, abnormal reading speed results, and decreased visual function quality of life scores. Contrast sensitivity results were normal in 85 of 99 eyes tested. Most subjects had no meaningful change in BCVA during follow-up. Subjects who started carbonic anhydrase inhibitor (CAI) treatment at enrollment had improved BCVA (mean ± SD change 3.15 ± 7.8 ETDRS letters, with increase of ≥15 ETDRS letters at 8 of 110 visits [in 3 subjects]). There were no significant changes in other parameters tested. Conclusions: Structural and functional results were stable during the 18-month follow-up period. Some patients starting CAI treatment at the baseline visit showed improvement in BCVA that was not correlated with changes in CCV. Natural history data such as these will be important for comparisons to the changes in measures of retinal structure and function following gene replacement therapy in patients with XLRS.

Indexed as

AdolescentAdultAgedCarbonic Anhydrase InhibitorsChildContrast SensitivityElectroretinographyFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesQuality of LifeRetinaRetinoschisisTomography, Optical CoherenceCarbonic Anhydrase Inhibitors

Identifiers

PMID30551202
PMCPMC6295939
OpenAlexW2993965825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.